Abraxis BioScience, Inc. (“ABBI”) has announced a plan of business separation whereby each existing ABBI share will be converted into one APP Pharmaceuticals, Inc. (“APPX”) Common Share and .25 (New) Abraxis, Inc. (“ABII”) Common Shares.  The distribution is scheduled to become effective on November 14, 2007.

For the full text of this advisory . . .